2006 Consulting Diabetes Insurance 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. A lot of plans require a prior approval for each dose, and insurance plans are making access really difficult.”
Permanente Medicine
JUNE 3, 2025
I joined SCPMG straight from residency in 2006. Access is so important because that is the reason the patient signs up with health insurance is so that they can get care, whether primary or specialty. We have to get that right or else the patient [is] going to go to a different entity or a different insurance company.
Expert insights. Personalized for you.
66 
Let's personalize your content